ELUT logo

Elutia Inc

ELUT
Healthcare|Biotechnology|US
$0.84
+0.09 (+11.52%)
DCF Value
$0.08
Tangible Book / Share
$0.33
Graham Number
$2.94
Cash / Share
$0.66
Next Earnings Report
Mar 3, 2027
EPS est. -$0.13 · Revenue est. $1.0M
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.

Upcoming Data Readouts (1)

Dec 2026
Est. completion
Cardiac Arrhythmias
EluPro Antibiotic-Eluting BioEnvelope Registry
NCT06854081n=100

Recent Press Releases

Elutia Reports Third Quarter 2026 Results: As Plastic Surgeons Cite Infection Risk in Every Breast Research Session During National Meeting, NXT-41x Heads to FDA This Quarter, Fully Funded Through Launch
Nov 5, 2026 · GlobeNewsWire
Elutia to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026
Oct 22, 2026 · GlobeNewsWire
Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029
Oct 1, 2026 · GlobeNewsWire
Elutia to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 15th
Sep 10, 2026 · GlobeNewsWire
Elutia to Participate in the Lake Street Capital Markets 10th Annual Big Ideas Growth Conference & the H.C. Wainwright 28th Annual Global Investment Conference
Sep 2, 2026 · GlobeNewsWire
Cellution Biologics Completes Acquisition of SimpliDerm® from Elutia Inc.
Aug 18, 2026 · GlobeNewsWire
Elutia Completes SimpliDerm® Sale on Schedule, Adds $8 Million in Cash to Fund NXT-41x Through Full Commercial Launch
Aug 18, 2026 · GlobeNewsWire
Elutia Secures Up to $26 Million to Fund NXT-41x Through Commercial Launch; Reports Second Quarter 2026 Results
Aug 13, 2026 · GlobeNewsWire
Elutia Secures $15 Million Loan Financing from Avenue Capital Group to Fund NXT-41x Launch in $1.5 Billion Plastic and Reconstructive Surgery Market
Aug 13, 2026 · GlobeNewsWire

SEC Filings (60)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 5, 20268-KMaterial eventDocumentIndex
Aug 21, 20268-KMaterial eventDocumentIndex
Aug 14, 2026S-8Employee stock planDocumentIndex
Aug 14, 202610-QQuarterly reportDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 13, 20268-KMaterial eventDocumentIndex
Aug 11, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 7, 20268-KMaterial eventDocumentIndex
Jul 20, 20268-KMaterial eventDocumentIndex
Jun 16, 20268-KMaterial eventDocumentIndex
May 15, 202610-QQuarterly reportDocumentIndex
May 14, 20268-KMaterial eventDocumentIndex
Apr 22, 2026ARSAnnual report to holdersDocumentIndex
Apr 22, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 22, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 25, 2026S-8Employee stock planDocumentIndex
Mar 13, 202610-KAnnual reportDocumentIndex
Mar 11, 20268-KMaterial eventDocumentIndex
Mar 9, 20268-KMaterial eventDocumentIndex
Mar 4, 20268-KMaterial eventDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 13, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jan 28, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jan 12, 20268-KMaterial eventDocumentIndex
Jan 2, 20268-KMaterial eventDocumentIndex
Dec 15, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Nov 12, 202510-QQuarterly reportDocumentIndex
Nov 12, 20258-KMaterial eventDocumentIndex
Nov 6, 20258-KMaterial eventDocumentIndex
Oct 14, 20258-KMaterial eventDocumentIndex
Oct 7, 20258-KMaterial eventDocumentIndex
Sep 9, 20258-KMaterial eventDocumentIndex
Aug 20, 20258-KMaterial eventDocumentIndex
Aug 14, 202510-QQuarterly reportDocumentIndex
Aug 14, 20258-KMaterial eventDocumentIndex
Jun 4, 20258-KMaterial eventDocumentIndex
May 15, 2025SC 13G/APassive 5%+ stakeDocumentIndex
May 15, 2025SC 13GPassive 5%+ stakeDocumentIndex
May 13, 202510-QQuarterly reportDocumentIndex